HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus
KA Lurain, R Ramaswami, LT Krug… - Clinical Microbiology …, 2024 - journals.asm.org
Within weeks of the first report of acquired immunodeficiency syndrome (AIDS) in 1981, it
was observed that these patients often had Kaposi sarcoma (KS), a hitherto rarely seen skin …
was observed that these patients often had Kaposi sarcoma (KS), a hitherto rarely seen skin …
Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV
JM Benito, C Restrepo, J García-Foncillas… - Frontiers in …, 2023 - frontiersin.org
The immune system of people living with HIV (PLWH) is persistently exposed to antigens
leading to systemic inflammation despite combination antiretroviral treatment (cART). This …
leading to systemic inflammation despite combination antiretroviral treatment (cART). This …
[HTML][HTML] 6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7)
F Cardoso, S Paluch-Shimon, E Schumacher-Wulf… - The breast, 2024 - Elsevier
This manuscript describes the Advanced Breast Cancer (ABC) international consensus
guidelines updated at the last two ABC international consensus conferences (ABC 6 in …
guidelines updated at the last two ABC international consensus conferences (ABC 6 in …
Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment
Y Liu, H Yang, T Li, N Zhang - Frontiers in Immunology, 2024 - frontiersin.org
Liver cancer is a major global health concern, ranking among the top causes of cancer-
related deaths worldwide. Despite advances in medical research, the prognosis for liver …
related deaths worldwide. Despite advances in medical research, the prognosis for liver …
Treating cancer in people with HIV
K Lurain - Journal of Clinical Oncology, 2023 - ascopubs.org
The Oncology Grand Rounds series is designed to place original reports published in the
Journal into clinical context. A case presentation is followed by a description of diagnostic …
Journal into clinical context. A case presentation is followed by a description of diagnostic …
Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi Sarcoma
K Lurain, R Ramaswami, I Ekwede, V Eulo… - Journal of Clinical …, 2024 - ascopubs.org
PURPOSE Cancer Immunotherapy Trials Network 12 demonstrated safety of
pembrolizumab in treating advanced cancer in people with HIV. Here, we report results of …
pembrolizumab in treating advanced cancer in people with HIV. Here, we report results of …
[HTML][HTML] An updated review of immune checkpoint inhibitors in cutaneous oncology: Beyond melanoma
Over the last decade, immune checkpoint inhibitors (ICIs) have been established as an
integral component of the contemporary anticancer armamentarium. In dermatology, ICIs are …
integral component of the contemporary anticancer armamentarium. In dermatology, ICIs are …
Advances and clinical applications of immune checkpoint inhibitors in hematological malignancies
W Sun, S Hu, X Wang - Cancer Communications, 2024 - Wiley Online Library
Immune checkpoints are differentially expressed on various immune cells to regulate
immune responses in tumor microenvironment. Tumor cells can activate the immune …
immune responses in tumor microenvironment. Tumor cells can activate the immune …
Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective
S Poletto, L Paruzzo, A Nepote, D Caravelli… - Cancers, 2023 - mdpi.com
Simple Summary Metastatic melanoma treatment has greatly changed in the last decade
due to the introduction of target therapies and immune checkpoint inhibitors. The …
due to the introduction of target therapies and immune checkpoint inhibitors. The …
Navigating practical challenges in immunotherapy for metastatic triple negative breast cancer
L Licata, MV Dieci, C De Angelis, C Marchiò… - Cancer Treatment …, 2024 - Elsevier
Immunotherapy has revolutionized cancer therapy and now represents a standard of care
for many tumor types, including triple-negative breast cancer. Despite the positive results …
for many tumor types, including triple-negative breast cancer. Despite the positive results …